Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FXG44
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,439
Award facts
- Contract value 100% obligated
- $16,439.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on September 10, 2025, by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $16,439.35 for the supply of Gemtesa 75 mg tablets in quantities of 30 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical federal vendor for pharmaceutical procurement across military and veteran healthcare systems. As a primary pharmaceutical supplier to the Defense Health Agency and related federal healthcare providers, the company maintains an extensive portfolio of brand-name and generic medications through its DLA prime vendor contract. This particular order for Gemtesa, a medication for overactive bladder treatment, exemplifies the company's role in supporting the Medical Supply Chain for federal military healthcare programs. The competitively awarded delivery order structure under the broader IDC demonstrates AmerisourceBergen's capability to fulfill diverse pharmaceutical requirements at varying price points and volumes to meet Defense Department healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FXG44?
SPE2DB25FXG44 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FXG44 worth?
The government has obligated $16,439 on SPE2DB25FXG44.
Is contract SPE2DB25FXG44 an order under another contract?
Yes. SPE2DB25FXG44 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXG44 competed?
The extent of competition for SPE2DB25FXG44 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award